ArticleTranslational andrology and urology2026
Circulating tumor DNA as a prognostic biomarker in adjuvant nivolumab therapy for high-risk muscle-invasive urothelial carcinoma: insights from CheckMate 274 and beyond.
Shugo Yajima et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.